From Lab to Market: Funding and Commercialization Support for Scientist Entrepreneurs and Early-stage Start-ups from the National Cancer Institute - Presentation and 1-on-1 Meetings!
The federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are a critical source of non-dilutive funding for early-stage companies. The National Cancer Institute (NCI) SBIR and STTR programs provide approximately $200 million annually to US small businesses for developing and commercializing novel cancer technologies. In addition to funding, the NCI SBIR Development Center offers various commercialization resources to support small businesses in getting their products into the market.
Join the webinar to learn about:
* NCI SBIR / STTR programs
* Funding opportunities for start-ups, academic spinout companies, and early-stage academic entrepreneurs (e.g., postdoctoral fellows)
* Tips for writing competitive SBIR/STTR grant proposals.
* Commercialization resources for applicants and awardees
Date: Wednesday, October 23, 2024
Venue: Marcus Nanotechnology Building, 345, Ferst Drive, Atlanta, GA 30322
Agenda:
9:30 AM —10:00 AM Registration
10:00 AM—12:00 PM Presentations
12:00pm—12:30 PM Lunch & Networking
12:30 PM— 4:00 PM 1 x1 Meetings
Registration / Lunch reservation deadline: October 16, 2024. If you would like to meet with the NCI SBIR/STTR program directors for a 1 x 1 consultations, please indicate the same in the registration form.
Speaker Bios:
Dr. Monique Pond is a Team Leader & Program Director at the NCI SBIR Development Center. She manages a portfolio of grants and contracts to small businesses developing novel cancer therapeutics, digital health technologies, and therapeutic devices. Monique leads the CARE (Connecting Awardees with Regulatory Experts) program and other collaborative initiatives with the FDA to assist small businesses in navigating the regulatory pathway for their technology. Before joining the NCI SBIR Development Center in 2018, Monique spent several years as a regulatory consultant at a small start-up, providing clients with regulatory support for FDA, EMA, and other country submissions. She completed her postdoctoral research at the National Institute of Standards and Technology and earned a Ph.D. in chemistry from the Pennsylvania State University.
Dr. Swamy Tripurani is a Program Director at the NCI SBIR Development Center. He is responsible for managing a portfolio of grants and contracts that support the development of innovative cancer therapeutics, digital health technologies, and therapeutic devices by small businesses. He supports the CARE (Connecting Awardees with Regulatory Experts) program, facilitating interactions between NCI-funded small businesses and the Food and Drug Administration (FDA). Before joining NCI, Dr. Tripurani worked as a regulatory scientist at the FDA for eight years. Dr. Tripurani earned his Ph.D. in Genetics and Developmental Biology from West Virginia University and completed his postdoctoral research training focused on gynecologic cancers and reproductive disorders at Baylor College of Medicine.
Contact:
Paul Joseph, Ph.D., MBA
Principal, Quadrant-i
Office of Commercialization
Georgia Institute of Technology
paul.joseph@venturelab.gatech.edu
Register here